Participants see retatrutide as the likely next major weight-loss option after approval in a couple years, but view current media coverage as mostly hype that buries the mention. Oral small-molecule mimics are expected to gain early popularity for convenience yet lose out to injections on results. Concerns center on people trying orals first, getting poor outcomes, and dismissing peptides entirely as ineffective.
What this discussion establishesWhether retatrutide will clearly outperform tirzepatide for most users or if the extra metabolic boost feels off-putting.
Still openHow soon oral versions might reach injection-level efficacy and affordability, and whether media attention will actually drive meaningful demand shifts.
Nothing here is advice.
The press really gets on my nerves with their cheap automated nonsense. Still the piece does note that retatrutide will be the next big GLP option for weight loss once that firm secures approval. Grab supplies ahead of time. The follow-up to Ozempic looks like it could bring even bigger shifts.
Most folks won't even read it, and if they do they won't reach the part about reta since it's buried far down.
Odd how they only brought up reta one time and spent more space on the pill instead.
Plenty of people have been waiting on pills since they avoid having to inject. Pills are simpler to keep, measure out, and produce so they should cost less. The pills will draw interest early on but once users see they don't work as well the interest will drop off.
I'm hoping they can make the pills match the shots in results. I'm starting to feel uneasy about all the medical trash I'm adding to landfills from my current routine with clipped needles, wipes, and little glass vials. Multiply that across everyone now using these and pills that actually deliver would be a relief.
That's the difficult spot. I end up talking with others about these compounds and warn them not to take my word alone because it can sound unrealistic given how low the downsides seem versus regular medicines. People recall when certain pain relievers were called completely harmless. Once they start looking into it themselves they hit ads dressed up as research. The oral forms are getting pushed hard online because of the money behind them. I'm worried many who could gain from the compounds will try the oral route without realizing the gap in results and end up with little benefit then decide the whole idea is worthless.
Not really. It's the usual alarm stuff. The unofficial market will stay around. Keeping a normal supply that handles the usual disruptions once or twice a year is enough.
Still in phase 3 and likely a couple years from approval here. Nothing worth worrying about even after it clears.
Tiny-molecule compounds that copy what peptides do will probably take over eventually. Dual and triple versions in pill form should arrive. Shots remain too inconvenient for most even when the goal is weight loss.
I'd like to be wrong here and hope it happens sooner. I just doubt the timeline for it becoming real, available, and affordable.
I keep a sharps bin. Once full I mail it back in the original packaging using their prepaid label and they send a replacement. No charge and they take care of disposal per the instructions.
I bought the smallest amount possible last week. Their overall value already puts them near the top of the market so big further gains look limited. The pill versions should bring in lots of new users though so some growth is still possible.
Good move. I hold ten shares and am currently ahead by a few thousand. That almost covers my own supply cost. Price dipped today so I might sell part of it but still expect some further rise.
The article seemed aimed more at the pills. I'm doubtful about labeling reta as the direct follow-up to ozempic. Tirz deserves that spot more. I tried switching over recently and while the metabolic lift is clear it sometimes feels off and many might prefer the steadier feel from tirz.
If you have tried it, this topic is still open. Sign in to reply — it takes a minute.